tiprankstipranks
Trending News
More News >
Century Therapeutics (IPSC)
NASDAQ:IPSC
US Market
Advertisement

Century Therapeutics (IPSC) Financial Statements

Compare
209 Followers

Century Therapeutics Financial Overview

Century Therapeutics's market cap is currently $43.18M. The company's EPS TTM is $-0.38; its P/E ratio is ―; Century Therapeutics is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Century Therapeutics Earnings and Revenue History

Century Therapeutics Debt to Assets

Century Therapeutics Cash Flow

Century Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis